Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid

Current Drug Delivery

Volumn 5, Issue 2, 2008, Pages 108-113

  Tafaghodi, M ^a,b   Jaafari, M R ^a   Sajadi Tabassi, S A ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cationic liposomes; Cationic fusogenic liposome; Fusogenic liposome; Nasal immunization; Tetanus toxoid

Indexed keywords

CATIONIC FUSOGENIC LIPOSOME; CATIONIC LIPOSOME; FUSOGENIC LIPOSOME; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOSOME; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; NONHUMAN; NORMAL HUMAN; NOSE MUCOSA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODY FORMATION; CATIONS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; HEMOLYSIS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOSOMES; MEMBRANE FUSION; PARTICLE SIZE; RABBITS; TETANUS ANTITOXIN; TETANUS TOXOID;

EID: 42149111647     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720108783954833     Document Type: Article

References (35)

1. Alpar, H. O.; Bowen, J. C.; Brown, M. R. W. Int. J. Pharm., 1992, 88, 335.
2. Husband, A. J. Vaccine, 1993, 11, 107.
3. Bowersock, T. L.; Hogenesch, H.; Suckow, M.; Porter, R. E.; Jackson, R.; Park, H.; Park, K. J. Control. Release, 1996, 39, 209.
4. Rebelatto, M. C.; Guimond, P.; Bowersock, T. L.; HogenEsch, H. Vet. Immunol. Immunopathol., 2001, 83, 93.
5. Gombotz, W. R.; Wee, S. Adv. Drug Deliv. Rev., 1998, 31, 267.
6. McGhee, J. R.; Mestecky, J.; Dertzbaugh, M. T.; Eldridge, J. H.; Hirasawa, M.; Kiyono, H. Vaccine, 1992, 10, 75.
7. Barenholz, Y.; Crommelin, D. Liposomes as pharmaceutical dosage forms. In Encyclopedia of Pharmaceutical Technology; Swarbrick, J.; Boylan, E. Eds.; Marcel Dekker: New York, 1994; pp 1.
8. Gregoriadis, G.; Gursel, I.; Gursel, M.; McCormack, B. J. Control. Release, 1996, 41, 49.
9. Joseph, A.; Louria-Hayon, I.; Plis-Finarov, A.; Zeira, E.; Zakay-Rones, Z.; Raz, E.; Hayashi, T.; Takabayashi, K.; Barenholz, Y.; Kedar, E. Vaccine, 2002, 20, 3342.
10. Kim, C.-K.; Jeong, E. J. Int. J. Pharm., 1995, 115, 193.
11. Ahsan, F.; Rivas, I. P.; Khan, M. A.; Torres Suarez, A. I. J. Control. Release, 2002, 79, 29.
12. Nakanishi, T.; Kunisawa, J.; Hayashi, A.; Tsutsumi, Y.; Kubo, K.; Nakagawa, S.; Nakanishi, M.; Tanaka, K.; Mayumi, T. J. Control. Release, 1999, 61, 233.
13. Vyas, S. P.; Goswami, S. K.; Singh, R. Int. J. Pharm., 1995, 118, 23.
14. Gregoriadis, G.; da Silva, H.; Florence, A. T. Int. J. Pharm., 1990, 65, 235.
15. Diwan, M.; Tafaghodi, M.; Samuel, J. J. Control. Release, 2002, 85, 247.
16. Tafaghodi, M.; Sajadi Tabasi, S. A.; Jaafari, M. R. Int. J. Pharm., 2006, 319, 37.
17. Tafaghodi, M.; Sajadi Tabasi, S. A.; Jaafari, M. R. J. Biomat. Sci. Polym. Ed., 2006, 17, 909.
18. Diwan, M.; Khar, R. K.; Talwar, G. P. Vaccine, 2001, 19, 3853.
19. Dokmetjian, J.; Della Valle, C.; Lavigne, V.; de Lujan, C. M.; Manghi, M. A. Vaccine, 2000, 18, 2698.
20. Bjork, E.; Edman, P. Int. J. Pharm., 1990, 62, 187.
21. Bowersock, T. L.; Hogenesch, H.; Suckow, M.; Guimond, P.; Martin, S.; Borie, D.; Torregrosa, S.; Park, H.; Park, K. Vaccine, 1999, 17, 1804.
22. Suckow, M. A.; Jarvinen, L. Z.; HogenEsch, H.; Park, K.; Bowersock, T. L. J. Control. Release, 2002, 85, 227.
23. de Haan, A.; Geerligs, H. J.; Huchshorn, J. P.; van Scharrenburg, G. J. M.; Palache, A. M.; Wilschut, J. Vaccine, 1995, 13, 155.
24. Abraham, E. Vaccine, 1992, 10, 461.
25. Brownlie, R. M.; Brahmbhatt, H. N.; White, D. C.; Fountain, M. W.; Rohde, M.; Wehland, J.; Timmis, K. N. Microb. Pathog., 1993, 14, 149.
26. Phillips, N. C.; Gagne, L.; Ivanoff, N.; Riveau, G. Vaccine, 1996, 14, 898.
27. Tafaghodi, M.; Jaafari, M. R.; Sajadi Tabassi, S. A. Eur. J. Pharm. Biopharm., 2006, 64, 138.
28. Stuart, B. O. Environ. Health Perspect., 1984, 55, 369.
29. Payne, J. M.; Sansom, B. F.; Garner, R. J.; Thomson, A. R.; Miles, B. J. Nature, 1960, 188, 586.
30. Eldridge, J. H.; Hammond, C. J.; Meulbroek, J. A.; Staas, J. K.; Gilley, R. M.; Tice, T. R. J. Control. Release, 1990, 11, 205.
31. Jaafari, M. R.; Tafaghodi, M.; Sajadi Tabasi, S. A. Iranian J. Pharm. Res., 2005, 4, 3.
32. Sakaue, G.; Hiroi, T.; Nakagawa, Y.; Someya, K.; Iwatani, K.; Sawa, Y.; Takahashi, H.; Honda, M.; Kunisawa, J.; Kiyono, H. J. Immunol., 2003, 170, 495.
33. de Haan, A.; Tomee, J. F.; Huchshorn, J. P.; Wilschut, J. Vaccine, 1995, 13, 1320.
34. de Haan, A.; Tomee, J. F. C.; Huchshorn, J. P.; Wilschut, J. Vaccine, 1995, 13, 1320.
35. Eyles, J. E.; Williamson, E. D.; Alpar, H. O. Int. J. Pharm., 1999, 189, 75.